performance scale ≤ 2; (3) evaluable disease with or without measurable lesions; (4) disease progression after previous chemotherapies within 3 months before entry, with a maximum of three previous regimens, including neoadjuvant or adjuvant chemotherapy; and (5) adequate hematological, renal, and...